drugset / Trial / NCT06489626

The Effect of a Methylprednisolone Taper on Outcomes Following Total Knee Arthroplasty

NCT06489626

Phase 4 Withdrawn F. Johannes Plate
RandomizedParallel-groupSingle-blindTreatment

Summary

Pain control and early range of motion following total knee arthroplasty are essential for patient satisfaction. Intraoperative steroids (dexamethasone) have been shown to have a significant effect in controlling acute pain following total knee arthroplasty. This study aims to evaluate the effect of a post-operative steroid (methylprednisolone) taper in improving functional and patient-reported outcomes following total knee arthroplasty. A taper means taking a high dose of a medication followed by taking lower doses and each following day until the medication is stopped.

Timeline

Start
2025-11-01
Primary completion
2027-10-01
Completion
2027-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylprednisolone Other / unclassified 4 mg Oral
Background Dexamethasone Small molecule 4 mg Intravenous

Indications